British Nuclear Medicine Society


The British Nuclear Medicine Society was established in 1966 and is an independent forum devoted to various aspects of nuclear medicine in the UK. The mission statement of BNMS is "the advancement of science and public education in Nuclear Medicine that would benefit patients."
As of 2020 the BNMS has over 600 members. The BNMS is a registered company and charity.

History

Founders Edward Williams, David Keeling, Steve Garnett, and Ralph McCready formed the society during a meeting held July 1966 at the Prince Alfred pub in Queensway, London. The BNMS began its life as a Nuclear Medicine Society, which was meant to enhance the future prospects of physicians in nuclear medicine. The first president of the society during 1968-69 was Clive J Hayter from Leeds. The organization held annual conferences since 1972. The BNMS hosted the second joint meeting under the presidency of Keith Britton in London in 1985, attended by 3000 participants.
In 2016, BNMS celebrated its fiftieth anniversary and published a 170-page "History of Radionuclide Studies in the UK".

Activities

BNMS publishes a monthly journal, Nuclear Medicine Communications.
Key events of the society include the biannual conference as well as participation in smaller, subject-specific, meetings and workshops.
BNMS publishes a range of guidance documents for nuclear medicine departments including on; patient information leaflets, the tendering of equipment, diagnostic imaging and non-imaging procedures, therapeutic procedures, and training requirements. Its clinical guidance is indexed in the National Institute for Health and Care Excellence evidence search.
The society and its UK Radiopharmacy Group provide resources for radiopharmacies in the UK, as well as work relating to supply issues for medical radionuclides, which largely come from outside the UK. This included several publications related to the impact of a no-deal Brexit.

Awards and fellowships

The Society sometimes gives awards to individuals and teams in the area of nuclear medicine in UK for using innovation and creativity to improve their service to public.